Clinical Trial Update: Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT) [Phase 3]

View source ↗

Summary

Phase 3 trial update for ticagrelor in pediatric patients with hepatic artery thrombosis after liver transplant; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Artery Thrombosis
• Liver Transplant Complications

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: RenJi Hospital | Conditions: Hepatic Artery Thrombosis, Liver Transplant; Complications | Phase 3 | Status: UNKNOWN